Health Care & Life Sciences » Pharmaceuticals | China Shineway Pharmaceutical Group Ltd.

China Shineway Pharmaceutical Group Ltd. | Ownership

Companies that own China Shineway Pharmaceutical Group Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Skagen AS (Investment Management)
22,953,000
2.78%
-3,540,000
0.45%
06/30/2018
Norges Bank Investment Management
11,357,963
1.37%
578,939
0%
12/31/2017
The Vanguard Group, Inc.
9,001,343
1.09%
-70,000
0%
07/31/2018
Dimensional Fund Advisors LP
6,225,200
0.75%
315,000
0%
04/30/2018
BlackRock Fund Advisors
4,461,000
0.54%
0
0%
09/06/2018
Schroder Investment Management Ltd.
4,306,000
0.52%
-954,000
0%
05/31/2018
AllianceBernstein Ltd.
4,108,000
0.5%
4,108,000
0.11%
03/31/2018
BNY Mellon Asset Management North America Corp.
2,542,000
0.31%
0
0%
09/06/2018
GAM Investment Management (Switzerland) AG
1,921,373
0.23%
-142,003
0.04%
05/31/2018
Numeric Investors LLC
1,821,000
0.22%
139,000
0.02%
06/29/2018

About China Shineway Pharmaceutical Group

View Profile
Address
Luan Cheng
Shijiazhuang Hebei 051430
China
Employees -
Website http://www.shineway.com
Updated 07/08/2019
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. Its products include Shen Mai injection, Qing Kai Ling injection, and Wu Fu Xin Nao Qing soft capsule. The company was founded by Zhen Jiang Li and Yun Xia Xin on August 14, 2002 and is headquartered in Shijiazhuang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.